» Articles » PMID: 17113338

The Regulation and Role of Osteopontin in Malignant Transformation and Cancer

Overview
Date 2006 Nov 23
PMID 17113338
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Osteopontin (OPN) is a predominantly secreted extracellular matrix glycophosphoprotein which binds to alpha v-containing integrins and has an important role in malignant cell attachment and invasion. High OPN expression in the primary tumor is associated with early metastasis and poor outcome in human breast and other cancers. Forced OPN overexpression in benign cells may induce neoplastic-like cell behaviour including increased attachment and invasion in vitro as well as the ability to metastasize in vivo. Conversely, OPN inhibition by antisense cDNA impedes cell growth and tumor forming capacity. OPN is not mutationally activated in cancer but its expression is regulated by Wnt/Tcf signaling, steroid receptors, growth factors, ras, Ets and AP-1 transcription factors. Presumably these factors are implicated in induction of OPN overexpression in cancer. Greater understanding of the role of OPN in neoplastic change and its transcriptional regulation may enable development of novel cancer treatment strategies.

Citing Articles

The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy.

Hildyard J, Riddell D, Harron R, Rawson F, Foster E, Massey C Wellcome Open Res. 2023; 7:238.

PMID: 36865375 PMC: 9971692. DOI: 10.12688/wellcomeopenres.18251.1.


Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells.

Ho N, Lin S, Lee Y, Tzeng C, Kao S Int J Mol Sci. 2022; 23(23).

PMID: 36499654 PMC: 9738877. DOI: 10.3390/ijms232315328.


Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding.

DeWitt S, Hoskinson Plumlee S, Brighton H, Sivaraj D, Martz E, Zand M JCI Insight. 2022; 7(17).

PMID: 36073547 PMC: 9536280. DOI: 10.1172/jci.insight.151583.


Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC).

Amilca-Seba K, Tan T, Thiery J, Louadj L, Thouroude S, Bouygues A Cells. 2022; 11(11).

PMID: 35681502 PMC: 9180003. DOI: 10.3390/cells11111808.


SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.

Wang M, Sun X, Xin H, Wen Z, Cheng Y Cancer Med. 2022; 11(23):4526-4543.

PMID: 35593388 PMC: 9741975. DOI: 10.1002/cam4.4840.